Custom formulation and R&D
Ayurvedic & nutraceutical formulation and R&D in India.
A useful product starts with a precise brief. Aayuritz supports formulation discussions for Ayurvedic and nutraceutical concepts, connecting botanical knowledge with the practical demands of format, taste, serving size, cost and manufacturing. Development is a sequence of decisions and trials, with the scope and approvals agreed before commercial production is considered.
Ayurveda and R&D are led by Dr. Chirag Patel, Managing Director and Director, Ayurveda & R&D. Meet our leadership

Define the job your product must do
Tell us the intended audience, product concept, target market and preferred format. Explain the experience you want to offer, such as a convenient capsule, a daily powder or a botanical blend. Product positioning and claims need their own review. A formulation brief should describe the requirements clearly without assuming that an ingredient choice alone proves a finished-product benefit.
Balance ingredients with real-world constraints
Development considers more than a list of ingredients. Taste, texture, fill weight, ingredient compatibility, sourcing and target cost can all affect the final product. Botanical extracts also need defined specifications, rather than interchangeable ingredient names.
- Preferred ingredients, exclusions and specification requirements
- Format, serving size and sensory preferences
- Target pack size, expected quantity and commercial budget
- Testing, shelf-life assessment and market review requirements to be scoped
Work through an agreed trial process
A development proposal should set out the deliverables, trial scope, sample quantities, feedback process and commercial terms. Review feedback against the brief so each revision has a clear purpose. A successful small trial does not automatically settle commercial production, packaging performance or shelf life. Those requirements should be addressed before the product moves to the next stage.
Keep the commercial handover clear
Once a formulation direction is accepted, the next discussion covers the production specification, packaging, testing requirements and commercial batch. Development fees, manufacturing costs and any applicable adjustment terms are separate items unless agreed otherwise. Ownership, confidentiality and exclusivity also need written terms rather than assumptions based on who first suggested the concept.
Bring references, not just aspirations
A reference product, ingredient shortlist or brief description of the customer need can make the first discussion more useful. Explain what you want to retain, improve or avoid. If there is a fixed budget, serving size or ingredient restriction, state it early. These constraints help focus the work on a product that can realistically move forward.
Turn the development brief into an agreed handover
Use these four checkpoints to define the work before a trial begins. The proposal should identify which deliverables are included, who approves them and how further revisions are handled.
- Brief and feasibility: record the ingredients, intended format, reference product, target market and commercial constraints. For a botanical ingredient such as Moringa leaf powder, define the material specification as well as the name.
- Trial and comparison: agree the trial scope and a comparison checklist for taste, texture, serving size or other relevant characteristics.
- Feedback and revision: collect feedback against that checklist and record the selected formulation version and unresolved requirements.
- Manufacturing handover: agree the production specification, packaging inputs, testing scope and approval responsibilities before a commercial batch is planned.
Connect the accepted direction with private label manufacturing and the relevant manufacturing format. Our specification and certificate of analysis guide explains how to frame analytical requirements. For an overseas launch, bring the destination-market and export documentation brief into the development discussion early.
Formulation development does not establish clinical efficacy. Analytical testing, stability work and clinical research require their own defined scope and supporting evidence.
Useful answers
Before we begin.
Can you develop a completely new formulation?
Share the concept for feasibility review. The development scope depends on the ingredients, format, intended market and required work. An initial discussion does not guarantee that every concept will be technically or commercially suitable.
Is formulation development included in manufacturing pricing?
Development and samples may be quoted separately from commercial production. The proposal should state what is included, the number or scope of trials, payment milestones and any agreed adjustment against later orders.
Does R&D include clinical testing?
Do not assume it does. Formulation development, analytical testing, stability work and clinical research are distinct activities. Any additional work must be explicitly discussed and included in the agreed scope.
Can you work towards a target price?
A target price helps guide ingredient, format and pack decisions. Feasibility still depends on the specification, order size and required work. Trade-offs should be discussed before approving a direction.
When can commercial manufacturing begin?
After the required formulation, specification, packaging and commercial approvals are complete. Any remaining testing or market requirements must also be addressed. Development timing and commercial lead time should be treated separately.
Start with the idea. Bring the constraints too.
Share your product concept, preferred format, target market and budget direction.